| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 140,664 | 127,337 | ||
| Marketable securities | 475,256 | 522,636 | ||
| Prepaid expenses and other current assets | 11,248 | 11,619 | ||
| Total current assets | 627,168 | 661,592 | ||
| Property and equipment, net | 1,228 | 1,289 | ||
| Right-of-use assets, operating leases | 1,220 | 1,340 | ||
| Other assets | 840 | 840 | ||
| Total assets | 630,456 | 665,061 | ||
| Accounts payable | 7,268 | 6,350 | ||
| Accrued external research and development expenses | 7,705 | 7,463 | ||
| Other accrued expenses | 11,115 | 6,161 | ||
| Operating lease liabilities, current | 656 | 632 | ||
| Total current liabilities | 26,744 | 20,606 | ||
| Principal term loan balance | 30,000 | - | ||
| Unamortized debt discount and issuance costs | 1,450 | - | ||
| Accrued end of term fee | 398 | - | ||
| Long-term debt, net | 28,948 | 28,737 | ||
| Operating lease liabilities, non-current | 1,373 | 1,553 | ||
| Total liabilities | 57,065 | 50,896 | ||
| Common stock, 0.0001 par value 100,000,000 shares authorized as of september 30, 2025 and december 31, 2024 35,006,636 and 29,865,030 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 4 | 3 | ||
| Additional paid-in capital | 1,022,324 | 1,001,223 | ||
| Accumulated other comprehensive income | 718 | 273 | ||
| Accumulated deficit | -449,655 | -387,334 | ||
| Total stockholders' equity | 573,391 | 614,165 | ||
| Total liabilities and stockholders' equity | 630,456 | 665,061 | ||
Disc Medicine, Inc. (IRON)
Disc Medicine, Inc. (IRON)